NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$60.98
+0.06 (+0.10%)
Open$60.60
Previous Close$60.92
Day High$61.82
Day Low$59.31
52W High$109.00
52W Low$8.27
Volume—
Avg Volume839.7K
Market Cap2.06B
P/E Ratio—
EPS$-8.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-30.7% upside
Current
$60.98
$60.98
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 110.61M | 131.16M | 246.52M |
| Net Income | -328,582,638 | -350,675,173 | 56.66M |
| Profit Margin | -297.1% | -282.2% | 23.0% |
| EBITDA | -278,515,123 | -313,754,733 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -15.7% | -15.7% | +15.2% |
| Debt/Equity | 0.70 | 0.70 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |